Premenstrual syndrome (PMS) affects the quality of life of millions of women. The complexity and variety of clinical presentation together with the cyclic recurrence of affective and somatic symptoms increase the difficulty in understanding and treating the disease. The precise pathophysiology of PMS is still unknown, but it is increasingly believed that, in women with PMS, the sensitive equilibrium between sex-steroids and central neurotransmitters is altered. Several studies have been carried out to understand the origin of the syndrome and to discover new ways of treatment. This review summarizes the most accepted PMS theories and treatments currently available based on the results of the best-designed trials.
Download full-text PDF |
Source |
---|
Arch Gynecol Obstet
March 2025
Royal Free London NHS Foundation Trust, London, UK.
Purpose: Alongside being contraceptives, progestins have been investigated as potential anti-inflammatory and analgesic therapies for use in painful gynaecological conditions. This review aims to synthesise evidence pertaining to the efficacy of progestins as analgesics for use in endometriosis, fibroids and pre-menstrual syndrome (PMS).
Methods: We conducted a systematic review of the extant literature investigating the analgesic efficacy of progestins compared to any comparator interventions for individuals with the three specified gynaecological conditions.
J Steroid Biochem Mol Biol
March 2025
Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California. Electronic address:
Context: Polycystic ovarian syndrome (PCOS) is an endocrine disorder affecting 10-15% of women of reproductive age, with significant implications for both physical and mental health. Several recent research studies have examined the connection between PCOS and psychiatric disorders; however, the mechanism linking the two is not fully understood. Allopregnanolone is a neurosteroid that modulates GABA receptors and is naturally affected by the pathophysiology of PCOS.
View Article and Find Full Text PDFDiscov Ment Health
March 2025
Department of Midwifery, Faculty of Medicine, Islamic Azad University-Sanandaj Branch, Sanandaj, Iran.
Background: Premenstrual syndrome (PMS) refers to significant clinical physical and psychological manifestations during the luteal phase of the menstrual cycle, leading to significant distress and impaired functional capacity. Given the side effects caused by pharmacotherapy, it seems logical to use non-pharmacological methods that can reduce symptoms such as menstrual stress. Thus, this study has been conducted to compare the effect of teaching coping skills and acupressure on premenstrual stress in undergraduate students of the Medical School of Azad University of Sanandaj-Iran.
View Article and Find Full Text PDFTaiwan J Obstet Gynecol
March 2025
Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
Objective: To investigate the prevalence of PMS and depressive symptoms and to determine their association among Korean adolescent girls using a nationally representative cross-sectional survey.
Materials And Methods: The Korean Study of Women's Health Related Issues (K-Stori)was used. Of the 3000 adolescent girls aged 14-17 years, the study subjects were 2970 girls after menarche.
Arch Public Health
March 2025
Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Emphasizing the historical exclusion of women from medical research, our letter sheds light on the double stigma of menstruation and premenstrual disorders faced by Middle Eastern women, and calls for collaborative efforts among healthcare professionals and policymakers to implement comprehensive anti-stigma strategies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!